ConductScience.org, home

Paper40969871

Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron Incorporation.

Gold HB and 17 others. ACS Pharmacol Transl Sci, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron Incorporation. Papers, record 40969871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40969871

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Next-Generation Lipid Prodrugs Orally Deliver Tenofovir via Enhanced Chylomicron Incorporation.
PubMed
Journal
ACS Pharmacol Transl Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-17
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gold HBHannah Beth
2Pribut NNicolehttps://orcid.org/0000-0003-0439-9162
3Outtrim ELEsther L
4Davidson PPriscilla
5Monaco CMChristopher Mhttps://orcid.org/0000-0001-7802-6188
6Myers AAugust
7Sun CQCarrie Qi
8Coskun GPGoknil Pelin
9Mancia AAndrea
10Yang YYanli
11Burton SSamantha
12Aftab AAreeb
13Derdeyn CACindy A
14Arnold RSRebecca S
15Petros JAJohn A
16Liu KKen
17Miller EJEric Jhttps://orcid.org/0000-0003-3659-0105
18Liotta DCDennis Chttps://orcid.org/0000-0002-7736-7113

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 GM145445NIGMS NIH HHSUnited StatesT32GM145445PubMedNIH RePORTER
R01 AI128837NIAID NIH HHSUnited StatesR01AI128837PubMed and NIHNIH RePORTER
UL1 TR000454NCATS NIH HHSUnited StatesUL1TR000454PubMedNIH RePORTER
S10 RR025679NCRR NIH HHSUnited StatesS10RR025679PubMedNIH RePORTER
R01 AI174979NIAID NIH HHSUnited StatesR01AI174979PubMed and NIHNIH RePORTER

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135496278Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport.Front Pharmacol2022https://conductscience.org/library/papers/35496278PubMed
235058937Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.Front Immunol2021https://conductscience.org/library/papers/35058937PubMed
39918041Fast ultracentrifugation methods for the separation of plasma lipoproteins.Methods Mol Biol1998https://conductscience.org/library/papers/9918041PubMed
436374157Placing CF2 in the Center: Major Physicochemical Changes Upon a Minor Structural Alteration in Gem-Difunctional Compounds.Chemistry2023https://conductscience.org/library/papers/36374157PubMed
511093912A new method for the study of chylomicron kinetics in vivo.Am J Physiol Endocrinol Metab2000https://conductscience.org/library/papers/11093912PubMed
634896450Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.J Control Release2022https://conductscience.org/library/papers/34896450PubMed
735179893Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles.J Med Chem2022https://conductscience.org/library/papers/35179893PubMed
821493074Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.Bioorg Med Chem2011https://conductscience.org/library/papers/21493074PubMed
938004512Development of a Novel In Vitro Model to Study Lymphatic Uptake of Drugs via Artificial Chylomicrons.Pharmaceutics2023https://conductscience.org/library/papers/38004512PubMed
103594676Synthesis and biological activity of fluorine-modified platelet activating factors.Chem Pharm Bull (Tokyo)1987https://conductscience.org/library/papers/3594676PubMed
1110929917Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.Clin Ther2000https://conductscience.org/library/papers/10929917PubMed
1211033424Rationale and applications of lipids as prodrug carriers.Eur J Pharm Sci2000https://conductscience.org/library/papers/11033424PubMed
1328885375Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report.Medicine (Baltimore)2017https://conductscience.org/library/papers/28885375PubMed
1428540164Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.Acta Pharm Sin B2017https://conductscience.org/library/papers/28540164PubMed
1538365068Novel solid self-emulsifying drug delivery system to enhance oral bioavailability of cabazitaxel.Int J Pharm2024https://conductscience.org/library/papers/38365068PubMed
1617646420Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17646420PubMed
1739240093Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/39240093PubMed
1830554119Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer.Biomed Pharmacother2019https://conductscience.org/library/papers/30554119PubMed
1916279790Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.J Med Chem2005https://conductscience.org/library/papers/16279790PubMed
2030025212Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.Expert Opin Drug Deliv2018https://conductscience.org/library/papers/30025212PubMed

See all 62 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42965765Intervening in Adipocyte Senescence: Lipid Prodrugs as an Emerging Strategy for Metabolic Disease Treatment.Curr Med Sci2026https://conductscience.org/library/papers/42965765PubMed
42280151Fatty Acids in Cancer Therapy: Chemical Conjugates, Nanocarriers, and Therapeutic Opportunities.Molecules2026https://conductscience.org/library/papers/42280151PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40969871

GET https://conductscience.org/api/papers/v1/40969871/references?page=2